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Mitochondrial reactive oxygen species control the transcription
factor CHOP-10/GADD153 and adipocyte differentiation: a
mechanism for hypoxia-dependent effect
Abstract
Recent reports emphasize the importance of mitochondria in white adipose tissue biology. In addition to
their crucial role in energy homeostasis, mitochondria are the main site of reactive oxygen species
generation. When moderately produced, they function as physiological signaling molecules. Thus,
mitochondrial reactive oxygen species trigger hypoxia-dependent gene expression. Therefore the present
study tested the implication of mitochondrial reactive oxygen species in adipocyte differentiation and
their putative role in the hypoxia-dependent effect on this differentiation. Pharmacological
manipulations of mitochondrial reactive oxygen species generation demonstrate a very strong and
negative correlation between changes in mitochondrial reactive oxygen species and adipocyte
differentiation of 3T3-F442A preadipocytes. Moreover, mitochondrial reactive oxygen species
positively and specifically control expression of the adipogenic repressor CHOP-10/GADD153.
Hypoxia (1% O2) strongly increased reactive oxygen species generation, hypoxia-inducible factor-1 and
CHOP-10/GADD153 expression, and inhibited adipocyte differentiation. All of these
hypoxia-dependent effects were partly prevented by antioxidants. By using hypoxia-inducible
factor-1alpha (HIF-1alpha)-deficient mouse embryonic fibroblasts, HIF-1alpha was shown not to be
required for hypoxia-mediated CHOP-10/GADD153 induction. Moreover, the comparison of hypoxia
and CoCl2 effects on adipocyte differentiation of wild type or HIF-1alpha deficient mouse embryonic
fibroblasts suggests the existence of at least two pathways dependent or not on the presence of
HIF-1alpha. Together, these data demonstrate that mitochondrial reactive oxygen species control
CHOP-10/GADD153 expression, are antiadipogenic signaling molecules, and trigger
hypoxia-dependent inhibition of adipocyte differentiation.
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Recent reports emphasize the importance of mito-
chondria in white adipose tissue biology. In addition to
their crucial role in energy homeostasis, mitochondria
are the main site of reactive oxygen species generation.
When moderately produced, they function as physiolog-
ical signaling molecules. Thus, mitochondrial reactive
oxygen species trigger hypoxia-dependent gene expres-
sion. Therefore the present study tested the implication
of mitochondrial reactive oxygen species in adipocyte
differentiation and their putative role in the hypoxia-
dependent effect on this differentiation. Pharmacologi-
cal manipulations of mitochondrial reactive oxygen spe-
cies generation demonstrate a very strong and negative
correlation between changes in mitochondrial reactive
oxygen species and adipocyte differentiation of 3T3-
F442A preadipocytes. Moreover, mitochondrial react-
ive oxygen species positively and specifically control
expression of the adipogenic repressor CHOP-10/
GADD153. Hypoxia (1% O2) strongly increased reactive
oxygen species generation, hypoxia-inducible factor-1
and CHOP-10/GADD153 expression, and inhibited adipo-
cyte differentiation. All of these hypoxia-dependent ef-
fects were partly prevented by antioxidants. By using
hypoxia-inducible factor-1 (HIF-1)-deficient mouse
embryonic fibroblasts, HIF-1 was shown not to be re-
quired for hypoxia-mediated CHOP-10/GADD153 induc-
tion. Moreover, the comparison of hypoxia and CoCl2
effects on adipocyte differentiation of wild type or
HIF-1 deficient mouse embryonic fibroblasts suggests
the existence of at least two pathways dependent or not
on the presence of HIF-1. Together, these data demon-
strate that mitochondrial reactive oxygen species con-
trol CHOP-10/GADD153 expression, are antiadipogenic
signaling molecules, and trigger hypoxia-dependent in-
hibition of adipocyte differentiation.
White adipose tissue is the main energy store in adult mam-
mals and displays great plasticity according to the energy
needs of the organism. Adipocyte differentiation results from a
subtle balance of sequential and interdependent transcription
factors expression that activate or inhibit promoters of adipo-
genic genes. Three members of the CAAT/enhancer binding
protein (C/EBP)1 family, C/EBP, C/EBP, and CHOP-10/
GADD153 (C/EBP homologous protein also identified as
growth arrest and DNA damage 153), are expressed early in
the adipocyte differentiation process. By forming heterodimers
with the other C/EBPs, CHOP-10/GADD153 acts as a domi-
nant negative regulator of C/EBP (1). During the clonal expan-
sion phase, CHOP-10/GADD153 expression falls and, simulta-
neously, C/EBP and C/EBP are transiently induced. This
mediates the later expression of C/EBP and peroxisome pro-
liferation-activated receptor-, subsequently triggering full-
blown adipocyte differentiation (2). Adipogenic hormones and
nutrients are well known to stimulate adipocyte differentiation
(3). However, hypoxia strongly inhibits this process (4).
The involvement of mitochondria in adipose tissue plasticity
has been neglected until now. Indeed, it was only recently
demonstrated that mitochondrial apparatus was a fundamen-
tal aspect of white fat and adipocyte differentiation (5, 6). Thus,
the concept that mitochondria could play an essential role in
white adipose tissue development is now emerging. This is
consistent with another study, which reports that genes encod-
ing components of the mitochondrial respiratory chain play an
essential role in lipid storage (7). Beside their key role in ATP
production, mitochondria constitute the primary source of re-
active oxygen species (ROS) generation in many cells. Indeed,
during respiration, a small but significant proportion of O2
molecules are converted to superoxide anion radical (O2
.) by
complex I and complex III according to their steady state re-
duction (8) (see Fig. 1A). This radical is subsequently diverted
into secondary products such as hydrogen peroxide (H2O2) and
hydroxyl radical (OH) via O2
. dismutation and Fenton reaction,
respectively. The continuous and high generation of mitochon-
drial ROS has generally been considered in the context of
degenerative diseases and aging (9). However, the concept that
according to the yield and the time course of mitochondrial
ROS generation they also function as physiological signaling
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molecules is now accepted (10–12). For instance, various re-
ports indicate that mitochondrial ROS act as a second messen-
ger in the O2 sensing mechanism to trigger erythropoietin and
vascular endothelium growth factor gene transcription via hy-
poxia-inducible factor-1 (HIF-1) (13).
Previously, we demonstrated that mitochondrial ROS influ-
ence the size of the white preadipocyte pool (14). This led us to
postulate that mitochondrial ROS could also participate in
adipocyte differentiation. Using pharmacological strategies,
first we confirmed this hypothesis. Second, we focused our
investigation on CHOP-10/GADD153 transcription factor as a
putative target of mitochondrial ROS. Indeed among the early
expressed transcription factors, it is well known to be sensitive
to ROS. Finally, we further tested whether hypoxia-dependent
inhibition of adipocyte differentiation could be mediated by
mitochondrial ROS generation.
EXPERIMENTAL PROCEDURES
Chemicals—Mitochondrial inhibitors (antimycin, rotenone, and
propofol), pyrrolidine dithiocarbamate (PDTC), carbonyl cyanide m-
chlorophenylhydrazone (CCCP), CoCl2, N-acetylcysteine, and actino-
mycin D were purchased from Sigma. Manganese (III) tetrakis (4-
benzoic acid) porphyrin (MnTBAP) was obtained from Calbiochem.
Cell Culture Conditions—3T3-F442A preadipocytes were routinely
cultivated (14) in a 21% O2, 74% N2, and 5% CO2 humidified atmo-
sphere. For the different experiments, cells were seeded at 5500 cells/
cm2 and were grown to confluence (day 0). At day 0, medium was
changed, mitochondrial inhibitors were added as indicated, and cell
cultures were stopped at different times. When cell cultures were main-
tained more than 2 days after day 0, medium without inhibitors (except
when indicated) was replaced. In hypoxia experiments, confluent cells
were maintained in hypoxic conditions (1% O2, 94% N2, 5% CO2; work
station BugBox, Jouan S.A.) and cultures were stopped at different
times. Cells were preincubated with antioxidants at day 1. In some
experiments, an uncoupler (CCCP) was added 5 min before the addition
of antimycin. Antioxidants and CCCP also were present during the
incubation period.
Mouse embryonic fibroblast (MEF) cells were induced to differentiate
2 days after confluence with the same medium as for 3T3-F442A (14)
supplemented with 10 g/ml insulin, 1 M dexamethasone, 0.5 mM
isobutylmethylxanthine, and 5 M rosiglitazone. Three days later, me-
dium containing 1 g/ml insulin and 5 M rosiglitazone was replaced
and then changed every day (4). To evaluate the hypoxia or CoCl2
effects on adipogenesis, cells were treated 2 days after confluence.
Determination of Intracellular ROS Generation—Intracellular ROS
generation was assessed using 6-carboxy-2,7-dichlorodihydrofluores-
cein diacetate, diacetoxymethylester (H2-DCFDA) (Molecular Probes)
(15). This probe enters the cells and is hydrolyzed to 6-carboxy-2,7-
dichlorodihydrofluorescein (H2-DCF). H2O2 and other peroxides cause
oxidation of H2-DCF, yielding the fluorescent product DCF. Confluent
cells were loaded with H2-DCFDA (2 M) 30 min before the end of the
incubation period (1 h in presence of the mitochondrial inhibitor). After
washing twice with phosphate-buffered saline, cells were collected in
water to disrupt cell membranes. Fluorescence (excitation 493 nm,
emission 527 nm) and protein content (16) then were measured. The
intensity of fluorescence was expressed as arbitrary units per milligram
of protein.
For ROS measurement in hypoxic conditions, cells were incubated
with H2-DCFDA for 2 h while the head space was gassed with 1% O2,
94% N2, and 5% CO2 (13). Cells were immediately treated as described
above. Data are normalized to values obtained from normoxic controls.
Measurement of Glycerol-3-phosphate-dehydrogenase (GPDH) Activ-
ity and Triglyceride Content—GPDH activity was measured as de-
scribed previously (17). Enzyme activity is reflected by the disappear-
ance of NADH, and results were expressed as nmol/min/mg of protein.
Cellular triglyceride content was determined using a commercially
available test combination (Triglycerides enzymatiques PAP 150,
Biomerieux).
Western Blot Analysis—Cells were collected on ice in 2 mM EDTA-
phosphate-buffered saline. After centrifugation at 600  g (4 °C, 10
min) pellets were resuspended in lysis buffer (50 mM Hepes, 250 mM
NaCl, 0.5% Triton X-100, pH 7), containing 1 mM Na3VO4 and protease
inhibitors (10 g/ml leupeptin, 10 g/ml aprotinin, and 1 mM phenyl-
methanesulfonyl fluoride). 40 g of proteins were separated by 12.5%
SDS-PAGE and subjected to Western blot. Antibodies used were: anti-
CHOP-10/GADD153, anti-C/EBP (both diluted 1:300, Santa Cruz Bio-
technology, Inc.), or anti-HIF-1 (diluted 1/500, Novus Biological Sci-
ences). Immunostained proteins were visualized using the enhanced
chemiluminescence detection system (Amersham Biosciences).
RNA Extraction and Northern Blot Analysis—Total RNA from cells
was extracted using Tripure isolation reagent (Roche Applied Science). 20
g of total RNA were denatured, electrophoresed on 1.2 formaldehyde-
agarose gels, and subjected to Northern blot analysis. PCR product of
CHOP-10/GADD153 cDNA cloned into PGEM plasmid (primers were 5-
GGCACCTATATCTCATCCCC and 3-TGGTCTACCCTCAGTCCTCT-
CCT, from position 267 to 789 of the coding phase, GenBankTM accession
number BC013718) served as probe. Equal loading of gels was checked
out by hybridization with 36B4 probe (18). The cDNA probes were labeled
with [-32P]dCTP (Milan Panich Biomedical), using the RediprimeTM II
(Amersham Biosciences) random prime labeling system. Unincorporated
dNTPs were removed using Microspin S-200 HR columns (Amersham
Biosciences).
Statistical Analysis—Means S.E. were calculated, and statistically
significant differences between two groups were determined by Stu-
dent’s t test at p  0.05.
RESULTS
Antimycin Reduces Adipocyte Differentiation—Antimycin, a
well known inhibitor of complex III (Fig. 1B), was used at a
concentration of 20 nM, which induces only slight inhibition
(15%, data not shown) of cell respiration. At this concentration
and as expected, antimycin induced an increase in ROS gener-
ation (Fig. 2A). Chronic treatment with antimycin for 4 days
greatly inhibited GPDH activity (Fig. 2B) and triglyceride con-
tent (38  3% versus control cells, p  0.001, data not shown),
two indexes of adipocyte differentiation. To identify a putative
critical sensitivity period, confluent cells were transiently
treated with 20 nM antimycin, and GPDH activity was later
assessed on day 4. Fig. 2C shows that 8 or 24 h of transient
exposure from confluence was sufficient to significantly inhibit
GPDH activity. 48 h of treatment had a similar effect as the
chronic treatment (96 h). These data demonstrate that adipo-
cyte differentiation is inhibited by antimycin and that tran-
sient exposure to this molecule during commitment of preadi-
pocytes to adipocytes is sufficient for inhibition. Treatment
duration of 48 h was chosen for further investigations.
Effects of Pharmacological Modulations of Mitochondrial
ROS on Adipocyte Differentiation—As antimycin (and mito-
chondrial inhibitors in general) may affect not only ROS gen-
eration but also energetic status, complementary strategies
(Fig. 1) were needed to demonstrate the specific effects caused
by ROS.
First, the prevention of antimycin effects by the addition of
antioxidants was studied. MnTBAP, a superoxide dismutase
mimetic with catalase-like activity, and PDTC, a thiol-reduc-
tive and iron-chelating agent, were used to counteract ROS
generation (Fig. 1B). We chose concentrations of MnTBAP (50
M) and PDTC (5 M), which had no effect per se on ROS
generation and GPDH activity (data not shown). As expected,
an increase of DCF fluorescence induced by antimycin was
significantly prevented when MnTBAP or PDTC were added to
the culture medium (Fig. 3A). In parallel, GPDH activities in
MnTBAP- and PDTC-supplemented cells were significantly
higher compared with treatment with antimycin alone (Fig.
3D). Triglyceride content in MnTBAP- and PDTC-supple-
mented cells was also significantly higher compared with treat-
ment with antimycin alone (97.2  13.1% and 83.6  15.37%
versus 47.2  5.8%, p  0.01 and p  0.05, respectively, data
not shown).
Second, it has been demonstrated (19, 20) that an uncoupling
agent, CCCP, is able to stimulate O2
. generation induced by
antimycin (Fig. 1C). So, we tested the addition of CCCP on
antimycin effects on ROS generation and adipocyte differenti-
ation. ROS generation in 1 M CCCP-supplemented cells was
strongly and significantly increased compared with treatment
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with antimycin alone (Fig. 3B). At this concentration, CCCP
alone had no effect (data not shown). This was associated with
enhanced inhibition of GPDH activity when CCCP was added
to the culture medium compared with treatment with antimy-
cin alone (Fig. 3E). Moreover, triglyceride content was signifi-
cantly lower in CCCP-supplemented cells compared with treat-
ment with antimycin alone (40.2  2% versus 48  1.5%, p 
0.05) (data not shown).
Last, to definitively demonstrate the involvement of mito-
chondrial ROS in adipocyte differentiation, we compared two
inhibitors of complex I, rotenone and propofol (Fig. 1D). Propo-
fol also has the ability to scavenge free radicals (21). As for
antimycin, we used equiactive concentrations of rotenone (8
nM) and propofol (40 M), which induce only a 15% decrease in
cell respiration (data not shown). Fig. 3, C and F, show the
opposite effects of rotenone and propofol on DCF fluorescence
and GPDH activity. In these conditions, rotenone significantly
increased ROS generation (Fig. 3C) and significantly decreased
GPDH activity (Fig. 3F) and triglyceride content (76.7  3%,
p  0.001, data not shown). On the contrary, propofol signifi-
cantly decreased DCF fluorescence (Fig. 3C) and increased
GPDH activity (Fig. 3F) and triglyceride content (111.4 3.3%,
p  0.05, data not shown). Altogether, these three complemen-
tary strategies demonstrate a very strong and negative corre-
lation between changes in mitochondrial ROS and adipocyte
differentiation.
Effects of Pharmacological Modulations of Mitochondrial
ROS on CHOP-10/GADD153—The inhibition of adipocyte dif-
ferentiation by mitochondrial ROS generated early in the dif-
ferentiation process led us to focus on CHOP-10/GADD153, a
transcription factor that is expressed early and is known to be
ROS-sensitive (22, 23).
Treatment of confluent cells with antimycin for 24 h strongly
increased CHOP-10/GADD153 protein content. The addition of
antioxidants, MnTBAP or PDTC, prevented the increase of
CHOP-10/GADD153 (Fig. 4A). Moreover, CHOP-10/GADD153
protein content was greatly enhanced when cells were treated
with antimycin and CCCP together compared with treatment
with antimycin alone (Fig. 4B). Finally, whereas CHOP-10/
GADD153 was increased after rotenone treatment, no change
was observed with propofol (Fig. 4C). Thus, in all tested con-
ditions, changes in CHOP-10/GADD153 protein content were
positively correlated with mitochondrial ROS generation and
inversely correlated with adipocyte differentiation.
To test the specificity of these changes, we evaluated the
expression of C/EBP in the same conditions. Three isoforms of
C/EBP are present in cells: 35- and 32-kDa proteins known as
liver-enriched activating protein and a 20-kDa protein known
as liver-enriched inhibitory protein. The three mitochondrial
inhibitors (antimycin, rotenone, and propofol) induced a slight
increase of the liver-enriched activating protein/liver-enriched
inhibitory protein ratio (Fig. 4, A–C), but these modifications
were not associated with those of ROS generation nor with
inhibition of adipocyte differentiation. Taken together, these
results demonstrate that mitochondrial ROS positively and
specifically control CHOP-10/GADD153.
Hypoxia-dependent Effects on Adipocyte Differentiation and
CHOP-10/GADD153 Are Prevented by Antioxidants—Conflu-
ent cells submitted to hypoxia demonstrated a significant in-
crease of ROS generation (Fig. 5A), which is time-dependent
(data not shown). As expected, GPDH activity was significantly
inhibited by hypoxia compared with normoxia (Fig. 5B). This
was associated with a strong increase of CHOP-10/GADD153
protein content (Fig. 5C). MnTBAP addition partly but signif-
icantly prevented a hypoxia-dependent increase of ROS gener-
ation (Fig. 5A) as well as inhibition of GPDH activity (Fig. 5B)
and an increase in CHOP-10/GADD153 (Fig. 5C). Similar re-
sults were obtained with a glutathione precursor, N-acetylcys-
FIG. 1. Pharmacological strategies used to modulate mitochondrial ROS generation. A, approximately 1–3% of the O2 consumed by the
mitochondrial electron transport chain is incompletely metabolized and reduced into superoxide anion (O2
.) at the level of complexes I and III.
O2
. is subsequently diverted into other ROS as H2O2. B, antimycin inhibits complex III, inducing the accumulation of electrons and so increasing
O2
. generation. The use of antioxidants (MnTBAP and PDTC) in combination with antimycin prevents this increase of ROS generation. C, the
mitochondrial uncoupler CCCP increases electron flux into the respiratory chain and so enhances the accumulation of electrons at complex III
compared with antimycin alone. D, rotenone as well as propofol inhibits complex I, but the latter also can powerfully scavenge free radicals at the
site of O2
. generation.
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teine (5 mM) (data not shown). Hypoxia induced an increase in
liver-enriched activating protein and a decrease in liver-en-
riched inhibitory protein content, which was not prevented by
MnTBAP addition (data not shown). Altogether, these data
suggest that mitochondrial ROS generation and CHOP-10/
GADD153 induction could specifically mediate hypoxia-
dependent effects on adipocyte differentiation.
Hypoxia-dependent Induction of CHOP-10/GADD153 Ex-
pression Requires a Transcriptional Mechanism—To elucidate
the mechanism of hypoxia-dependent CHOP-10/GADD153 in-
duction, Northern blotting experiments were performed. After
hypoxia exposure, a very rapid increase of CHOP-10/GADD153
mRNA level was detected (Fig. 6). Addition of actinomycin D
(10 g/ml), a transcription inhibitor, prevented CHOP-10/
GADD153 mRNA accumulation (Fig. 6). In these conditions, no
modification of 36B4 mRNA level was observed (data not
shown). These results demonstrate that hypoxia-dependent in-
duction of CHOP-10/GADD153 requires a transcriptional
mechanism.
Hypoxia-dependent Induction of CHOP-10/GADD153 Does
Not Require HIF-1 Expression—HIF-1 was described as me-
diating numerous hypoxia transcriptional effects (24). Its ac-
tivity depends on the interaction between aryl hydrocarbon
nuclear translocator (ARNT/HIF-1) constitutively expressed
and HIF-1, stabilized under hypoxic conditions (24). This led
us to investigate its putative involvement in hypoxia-depend-
ent inhibition of adipocyte differentiation. In basal conditions,
HIF-1 was not detected, and hypoxia induced the increase of
HIF-1 protein content in preadipocytes (Fig. 7A). The addition
of MnTBAP and N-acetylcysteine partly prevented this induc-
tion (Fig. 7A and data not shown, respectively) as it did for
CHOP-10/GADD153 (Fig. 5C).
Similar HIF-1 and CHOP-10/GADD153 variations under
our experimental conditions suggest a putative link between
both expressions. We compared hypoxia effects on MEF wild
type cells (HIF-1/) and cells deficient for the HIF-1 gene
(HIF-1/). HIF-1 detection by Western blotting analysis
confirms the identity of the HIF-1/ cell line (data not
shown). Hypoxia-dependent induction of CHOP-10/GADD153
was observed in both cell types (Fig. 7B) demonstrating that
HIF-1 is not required for hypoxia-mediated CHOP-10/
GADD153 induction.
As CoCl2 is often used as a chemical hypoxia mimetic for its
ability to stabilize HIF-1 protein, we investigated the effect of
CoCl2 on CHOP-10/GADD153. As expected, CoCl2 (100 M)
strongly induced HIF-1 (data not shown). A small increase in
CHOP-10/GADD153 protein content compared with that ob-
tained after hypoxia was observed in 3T3-F442A cells (only
10% compared with hypoxia, data not shown). Moreover, CoCl2
treatment had no effect on CHOP-10/GADD153 protein content
FIG. 2. Antimycin reduces adipo-
cyte differentiation. A, confluent 3T3-
F442A preadipocytes were incubated for
1 h in the presence of 20 nM antimycin (A).
Thirty min before the end of the incuba-
tion period, cells were loaded with H2-
DCFDA. Fluorescence was expressed as
arbitrary units per milligram of protein.
B, cells were incubated with 20 nM anti-
mycin for 96 h, and GPDH specific activ-
ity was assessed. C, cells were transiently
incubated with 20 nM antimycin for 8, 24,
48, or 96 h. GPDH activity was assessed
96 h after confluence. Data are the
mean  S.E. of n  3 independent exper-
iments (each experiment in triplicate).
***, p  0.001 versus control (C).
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in both MEF cell types (data not shown). These results show
that CoCl2 does not imitate the hypoxic conditions necessary
for CHOP-10/GADD153 induction.
Comparative Effects of Hypoxia and CoCl2 on GPDH Activi-
ties in HIF-1/ and HIF-1/ MEF—Whereas CoCl2
(100 M) significantly inhibited GPDH activity of HIF-1/
cells (42  12.7%, p  0.01), the HIF-1/ cells were not
significantly affected by CoCl2 treatment (106.25  6.7%) dem-
onstrating that CoCl2-dependent inhibition of adipocyte differ-
entiation is totally dependent on HIF-1 expression (Fig. 8A).
After hypoxia, GPDH activities of both HIF-1/ and HIF-
1/ cells types were significantly inhibited (49.5  4%, p 
0.001 and 69  8.4%, p  0.01 respectively, Fig. 8B), with
HIF-1/ cells less affected than the / ones. These results
show that hypoxia effects on adipocyte differentiation are not
completely reproduced by CoCl2 and could be triggered by at
least two signaling pathways, one HIF-1-dependent and the
other HIF-1-independent.
DISCUSSION
In this study, we provide strong evidence that mitochondrial
ROS control CHOP-10/GADD153 expression and adipocyte dif-
ferentiation. Moreover, we propose that this mechanism could
be involved in hypoxia-dependent inhibition of adipocyte
differentiation.
Various mitochondrial inhibitors can be used to induce the
accumulation of electrons inside the respiratory chain and in-
crease ROS generation. Unfortunately, their use has side ef-
fects on energetic status. This led us to develop different com-
plementary strategies to demonstrate the specific effects
FIG. 3. Effects of pharmacological modulations of mitochondrial ROS on adipocyte differentiation. A, confluent 3T3-F442A preadi-
pocytes were incubated for 1 h with 20 nM antimycin (A) with or without the addition of two antioxidants, 50 M MnTBAP or 5 M PDTC. Thirty
min before the end of the incubation period, cells were loaded with H2-DCFDA. Fluorescence was expressed as arbitrary units per milligram of
protein. B, cells were incubated for 1 h with 20 nM antimycin with or without the addition of an uncoupler, 1 M CCCP, and then were treated as
described in A. C, cells were incubated for 1 h with either 8 nM rotenone (R) or 40 M propofol (P) (these concentrations are equiactive on
mitochondrial respiration inhibition) and then were treated as described in A. D, cells were incubated for 48 h with 20 nM antimycin with or without
the addition of two antioxidants, MnTBAP or PDTC. GPDH-specific activity was assessed 96 h after confluence. E, cells were incubated for 48 h
with 20 nM antimycin with or without the addition of an uncoupler, CCCP, and then were treated as described in D. F, cells were incubated for
48 h with either 8 nM rotenone or 40 M propofol and then were treated as described in D. Data are the mean  S.E. of n  3 independent
experiments (each experiment in triplicate). *, p  0.05; **, p  0.01; ***, p  0.001 versus control (C). #, p  0.05; ##, p  0.01; ###, p  0.001
versus antimycin (A).
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caused by mitochondrial ROS: (i) the putative prevention of
antimycin (an inhibitor of complex III) effects by antioxidants;
(ii) the putative accentuation of antimycin effects by the addi-
tion of an uncoupler, CCCP, as previously demonstrated in
isolated mitochondria (19) and in intact cells (20); and (iii)
comparison between rotenone and propofol effects at concen-
trations equiactive on respiration. This last point is very in-
formative because rotenone generates ROS by inhibition of
complex I whereas propofol, which also inhibits complex I, has
the ability to powerfully scavenge free radicals at this site (21).
Whatever the strategies used, changes of mitochondrial ROS
generation are systematically closely and inversely associated
with the modulation of adipocyte differentiation. This clearly
demonstrates a great sensitivity of adipocyte differentiation to
mitochondrial ROS generation, which strongly participates in
the control of this process. Contrary to the strong extracellular
generation of ROS generally used, we induced only moderate
changes in mitochondrial ROS generation by very faint alter-
ations in mitochondria function. This is consistent with a role
for mitochondrial ROS as physiological signaling molecules
that control adipocyte differentiation. Moreover, we demon-
strated that transient mitochondrial ROS exposure at the time
of commitment is sufficient to later inhibit adipocyte differen-
tiation. This led us to postulate that transcription factors,
which play a key role early in adipocyte differentiation, i.e.
C/EBP transcription factors isoforms, may be targets for mito-
chondrial ROS.
Among C/EBP transcription factor isoforms, CHOP-10/
GADD153 expression has been shown to be regulated by vari-
ous stimuli including extracellular H2O2 (22, 23), mitochon-
drial stress (25), as well as hypoxia (26). Our results are
consistent with these data and demonstrate that in preadipo-
cytes CHOP-10/GADD153 but not other C/EBP isoform expres-
sion was always strongly correlated to the yield of mitochon-
drial ROS generation. Furthermore, we also provide evidence
for a close relationship between CHOP-10/GADD153 induction
and inhibition of adipocyte differentiation. As its overexpres-
sion in such cells efficiently represses their differentiation to-
FIG. 4. Effects of pharmacological modulations of mitochon-
drial ROS on CHOP-10/GADD153 and C/EBP protein content.
A, confluent 3T3-F442A preadipocytes were incubated with 20 nM an-
timycin (A) with or without the addition of two antioxidants, MnTBAP
or PDTC. After 24 h of incubation, whole cell lysates were prepared and
probed for the presence of CHOP-10/GADD153 or C/EBP by Western
blot analysis. B, cells were incubated with 20 nM antimycin with or
without the addition of an uncoupler, CCCP, and then were treated as
described in A. C, cells were incubated with either 8 nM rotenone or 40
M propofol and then were treated as described in A. Western blots are
representative of three independent experiments. LAP, liver enriched-
activating protein; LIP, liver enriched-inhibitory protein.
FIG. 5. Hypoxia-induced inhibition of adipocyte differentia-
tion is associated with ROS generation and CHOP-10 induction.
A, confluent 3T3-F442A preadipocytes were loaded with H2-DCFDA
and submitted to hypoxia (1% O2) for 2 h with or without the addition
of MnTBAP. Fluorescence was expressed as arbitrary units per milli-
gram of protein. B, cells were submitted to hypoxia (1% O2) for 24 h with
or without the addition of MnTBAP, and GPDH specific activity was
assessed. C, cells were submitted to hypoxia (1% O2) for 24 h with or
without the addition of MnTBAP. Whole cell lysates were prepared and
probed for the presence of CHOP-10 by Western blot analysis. ***, p 
0.001 versus normoxia; ###, p 0.001 versus hypoxia. Western blots are
representative of three independent experiments.
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ward the adipocyte phenotype (27, 1), this strongly suggests
that CHOP-10/GADD153 could mediate the mitochondrial ROS-
dependent inhibition of adipocyte differentiation.
Mitochondrial ROS are generated according to the con-
straints on respiratory chain components. They are proposed
as a metabolic sensor to adapt the cell fate to the metabolic
environment (12) but also as a component of the O2 sensing
mechanism. The relationship between hypoxia and ROS is
controversial. In a first model, ROS are generated by a mem-
brane-bound NADP(H) oxidase in direct proportion to the O2
concentration, and a decrease in ROS generation thus triggers
hypoxia-dependent effects (28). In a second model, hypoxia
partially inhibits mitochondrial electron transport, producing
redox changes in the electron carriers that increase ROS gen-
eration (13). One might assume that measurement of ROS
levels could be sufficient to distinguish between the two models
(29). In our conditions, hypoxia induced an increase in ROS
generation in confluent preadipocytes, validating the second
model. Hypoxia-dependent inhibition of adipocyte differentia-
tion was associated with an increase of HIF-1 and CHOP-10/
GADD153 protein content. All these hypoxia effects were pre-
vented by the addition of antioxidants suggesting that
mitochondrial ROS must be at the origin of hypoxia signaling
pathways in adipose cells.
Concomitant HIF-1 and CHOP-10/GADD153 increases and
the involvement of a transcriptional mechanism on CHOP-10/
GADD153 induction under hypoxia suggest a putative causal
link between both expressions. However, the use of HIF-1-
deficient mouse embryonic fibroblasts demonstrated that
HIF-1 is not required for hypoxia-mediated CHOP-10/
GADD153 induction. This agrees with a previous study that
clearly identified a set of genes up-regulated by hypoxia in an
HIF-1-independent manner (30). However, the involvement of
HIF-1 in hypoxia-dependent inhibition of adipocyte differen-
tiation was proposed (4). The conclusion of the authors was
achieved using a hypoxia chemical mimetic, i.e. CoCl2. Our
observations agree with their experimental data. Indeed,
CoCl2-mediated inhibition of adipocyte differentiation is totally
dependent on the presence of HIF-1. In such conditions, it is
noteworthy that CoCl2 does not strongly up-regulate CHOP-
10/GADD153 expression as hypoxia does as described on hu-
man cancer cells (31). Furthermore, hypoxia-mediated inhibi-
tion of adipocyte differentiation is only partly dependent on the
presence of HIF-1 (GPDH activity in HIF-1/ cells is in-
hibited by hypoxia in a lesser extent than in the / ones).
FIG. 6. Hypoxia-dependent induction of CHOP-10/GADD153
expression requires a transcriptional mechanism. Confluent 3T3-
F442A preadipocytes were submitted to hypoxia (1% O2) for 2, 4, or 8 h
with or without actinomycin D (10 g/ml), a transcription inhibitor.
Total RNA was extracted and Northern blots were prepared as de-
scribed under “Experimental Procedures.” The blots were hybridized
with a labeled probe corresponding to CHOP-10/GADD153. Northern
blots are representative of three independent experiments.
FIG. 7. Hypoxia-dependent induction of CHOP-10/GADD153
does not require HIF-1 expression. A, confluent 3T3-F442A pre-
adipocytes were submitted to hypoxia (1% O2) for 24 h with or without
the addition of MnTBAP. Whole cell lysates were prepared and probed
for the presence of HIF-1 by Western blot analysis. B, MEF wild type
(HIF-1/) and MEF deficient for the HIF-1 gene (HIF-1/) were
submitted to hypoxia for 24 h. Whole cell lysates were prepared and
probed for the presence of CHOP-10/GADD153 by Western blot analy-
sis. Western blots are representative of three independent experiments.
FIG. 8. Comparative effects of CoCl2 and hypoxia on GPDH
activities in HIF-1/ and HIF-1/ MEF. A, MEF wild type
(HIF-1/) and MEF deficient for HIF-1 gene (HIF-1/) were
incubated with 100 M CoCl2 for 6 days, and GPDH-specific activity was
assessed. B, MEF wild type (HIF-1/) and MEF deficient for the
HIF-1 gene (HIF-1/) were submitted to hypoxia for 24 h, and
GPDH-specific activity was assessed. Data are the mean  S.E. of n 
3 independent experiments (each experiment in triplicate). **, p 0.01;
***, p  0.001 versus normoxia; #, p  0.05 versus HIF-1/.
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Taken together, this clearly suggests the involvement of at
least two independent pathways in the hypoxia-mediated inhi-
bition of adipocyte differentiation, either dependent or inde-
pendent of HIF-1. This latter signaling pathway might be
triggered by CHOP-10/GADD153.
This study clearly demonstrates that mitochondrial ROS
must be considered as antiadipogenic signaling molecules. We
also suggest that mitochondrial ROS and CHOP-10/GADD153
belong to the intracellular O2 sensing mechanism of adipose
cells. This signaling pathway could be involved in limiting
growth of adipose tissue as described in other tissues (32, 33).
Moreover, ROS generation linked to mitochondrial dysfunction
could be directly involved in adipose tissues alterations associ-
ated with metabolic disorders (34). Taken together, these data
emphasize the importance of mitochondria and ROS in white
adipose tissue development and function.
Acknowledgments—We thank Dr. C. Toulas and C. Delmas for work
station BugBox and technical assistance and Drs. G. Mithieux and
A. Gauthier for help and advice. We are also grateful to N. Crowte for
help in the translation of the manuscript.
REFERENCES
1. Ron, D., and Habener, J. F. (1992) Genes Dev. 6, 439–453
2. Fajas, L., Fruchart, J. C., and Auwerx, J. (1998) Curr. Opin. Cell Biol. 10,
165–173
3. Ailhaud, G. (1995) Ann. Endocrinol. 562, 93–95
4. Yun, Z., Maecker, H. L., Johnson, R. S., and Giaccia, A. J. (2002) Dev. Cell 2,
331–341
5. Prunet-Marcassus, B., Moulin, K., Carmona, M. C., Villarroya, F., Pe´nicaud,
L., and Casteilla, L. (1999) FEBS Lett. 464, 184–188
6. Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K., Leszyk, J., Nicoloro, S.,
Czech, M., and Corvera, S. (2003) Mol. Cell. Biol. 23, 1085–1094
7. McKay, R. M., McKay, J. P., Avery, L., and Graff, J. M. (2003) Dev. Cell 4,
131–142
8. Turrens, J. F. (1997) Biosci. Rep. 17, 3–8
9. Cadenas, E., and Davies, K. J. (2000) Free Radic. Biol. Med. 29, 222–230
10. Casteilla, L., Rigoulet, M., and Pe´nicaud, L. (2001) IUBMB Life 52, 181–188
11. Finkel, T. (1998) Curr. Opin. Cell Biol. 10, 248–253
12. Nemoto, S., Takeda, K., Yu, Z. X., Ferrans, V. J., and Finkel, T. (2000) Mol.
Cell. Biol. 20, 7311–7318
13. Chandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez,
J. A., Rodriguez, A. M., and Schumacker, P. T. (2000) J. Biol. Chem. 275,
25130–25138
14. Carrie`re, A., Fernandez, Y., Rigoulet, M., Pe´nicaud, L., and Casteilla, L. (2003)
FEBS Lett. 550, 163–167
15. Ne`gre-Salvayre, A., Auge´, N., Duval, C., Robbesyn, F., Thiers, J. C., Nazzal, D.,
Benoist, H., and Salvayre, R. (2002) Methods Enzymol. 352, 62–71
16. Lowry, O. H., Rosebrough, N.J., Farr, A. L., and Randall, R. J. (1951) J. Biol.
Chem. 193, 265–275
17. Pairault, J., and Green, H. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 5138–5142
18. Krowczynska, A. M., Coutts, M., Makrides, S., and Brawerman, G. (1989)
Nucleic Acids Res. 17, 6408
19. Cadenas, E., and Boveris, A. (1980) Biochem. J. 188, 31–37
20. Gardner, P. R., Raineri, I., Epstein, L. B., and White, C. W. (1995) J. Biol.
Chem. 270, 13399–13405
21. Green, T. R., Bennett, S. R., and Nelson, V. M. (1994) Toxicol. Appl. Pharma-
col. 129, 163–169
22. Entingh, A. J., Law, B. K., and Moses, H. L. (2001) Endocrinology 142,
221–228
23. Guyton, K. Z., Xu, Q., and Holbrook, N. J. (1996) Biochem. J. 314, 547–554
24. Huang, L. E., and Bunn, H. F. (2003) J. Biol. Chem. 278, 19575–19578
25. Zhao, Q., Wang, J., Levichkin, I. V., Stasinopoulos, S., Ryan, M. T., and
Hoogenraad, N. J. (2002) EMBO J. 21, 4411–4419
26. Price, B. D., and Calderwood, S. K. (1992) Cancer Res. 52, 3814–3817
27. Batchvarova, N., Wang, X. Z., and Ron, D. (1995) EMBO J. 14, 4654–4661
28. Fandrey, J., Frede, S., and Jelkmann, W. (1994) Biochem. J. 303, 507–510
29. Semenza, G. L. (1999) Cell 98, 281–284
30. Carmeliet, P., Dor, Y., Herbert, J. M., Fukumura, D., Brusselmans, K.,
Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., Koch,
C. J., Ratcliffe, P., Moons, L., Jain, R. K., Collen, D., Keshert, E., and
Keshet, E. (1998) Nature 394, 485–490
31. Ameri, K., Lewis, C. E., Raida, M., Sowter, H., Hai, T., and Harris, A. L. (2004)
Blood 103, 1876–1882
32. Genbacev, O., Zhou, Y., Ludlow, J. W., and Fisher, S. J. (1997) Science 277,
1669–1672
33. Liebermann, D. A., and Hoffman, B. (2002) Leukemia 16, 527–541
34. Schrauwen, P., and Hesselink, M. K. C. (2004) Diabetes 53, 1412–1417
Redox Regulation of Adipocyte Differentiation 40469
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on July 3, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
